retatrutide trial results news today An experimental weight-loss drug from Eli Lilly looks like the most promising weight-loss drug ever tested, rivaling the of gastric bypass surgery. injections, designed to be taken once a week Lilly's Retatrutide Scores Triple Trial

It is important to remember that not all GLP-1 medications are expressly licensed for weight loss and that the doses used for weight loss may vary from those used for managing diabetes

These changes in body composition can feel frustrating and out of your control, but understanding them is the first step toward regaining that control

August 2024 A crucial status conference is scheduled for August 8 to address key legal issues, including Plaintiff Fact Sheets, discovery protocols, and the preparation for Science Day

Its completely normal to feel uncertain about starting a new medication, especially when it comes with potential side effects